Tsh Biopharmoration Net Income vs. Cash Per Share

8432 Stock  TWD 60.70  0.20  0.33%   
Considering Tsh Biopharmoration's profitability and operating efficiency indicators, tsh biopharmoration may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Tsh Biopharmoration's ability to earn profits and add value for shareholders.
For Tsh Biopharmoration profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tsh Biopharmoration to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well tsh biopharmoration utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tsh Biopharmoration's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of tsh biopharmoration over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Tsh Biopharmoration's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tsh Biopharmoration is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tsh Biopharmoration's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

tsh biopharmoration Cash Per Share vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Tsh Biopharmoration's current stock value. Our valuation model uses many indicators to compare Tsh Biopharmoration value to that of its competitors to determine the firm's financial worth.
tsh biopharmoration is number one stock in net income category among its peers. It also is number one stock in cash per share category among its peers . The ratio of Net Income to Cash Per Share for tsh biopharmoration is about  2,565,795 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tsh Biopharmoration's earnings, one of the primary drivers of an investment's value.

Tsh Cash Per Share vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Tsh Biopharmoration

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
47.11 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Tsh Biopharmoration

Cash Per Share

 = 

Total Cash

Average Shares

 = 
18.36 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

Tsh Cash Per Share Comparison

Tsh Biopharmoration is currently under evaluation in cash per share category among its peers.

Tsh Biopharmoration Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Tsh Biopharmoration, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tsh Biopharmoration will eventually generate negative long term returns. The profitability progress is the general direction of Tsh Biopharmoration's change in net profit over the period of time. It can combine multiple indicators of Tsh Biopharmoration, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
TSH Biopharm Corporation Limited develops, manufactures, and markets drugs for various chronic diseases in Taiwan and China. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited. TSH BIOPHARM is traded on Taiwan OTC Exchange in Taiwan.

Tsh Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Tsh Biopharmoration. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tsh Biopharmoration position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tsh Biopharmoration's important profitability drivers and their relationship over time.

Use Tsh Biopharmoration in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tsh Biopharmoration position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tsh Biopharmoration will appreciate offsetting losses from the drop in the long position's value.

Tsh Biopharmoration Pair Trading

tsh biopharmoration Pair Trading Analysis

The ability to find closely correlated positions to Tsh Biopharmoration could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tsh Biopharmoration when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tsh Biopharmoration - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling tsh biopharmoration to buy it.
The correlation of Tsh Biopharmoration is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tsh Biopharmoration moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if tsh biopharmoration moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tsh Biopharmoration can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Tsh Biopharmoration position

In addition to having Tsh Biopharmoration in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Entertainment Thematic Idea Now

Entertainment
Entertainment Theme
Companies from entertainment industry including show business, news and media. The Entertainment theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Tsh Stock Analysis

When running Tsh Biopharmoration's price analysis, check to measure Tsh Biopharmoration's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tsh Biopharmoration is operating at the current time. Most of Tsh Biopharmoration's value examination focuses on studying past and present price action to predict the probability of Tsh Biopharmoration's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tsh Biopharmoration's price. Additionally, you may evaluate how the addition of Tsh Biopharmoration to your portfolios can decrease your overall portfolio volatility.